DermaFlow
Detecting non-invasively earliest signs of acute & chronic health status; products transitioning hospital, out-patient & home/remote.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Plainsboro, NJ, USA
- Currency USD
- Founded November 2011
- Employees 7
- Incorporation Type LLC
- Website dermaflow.com
Company Summary
Microcirculation is a well known & researched parameter, but a device having optimal attributes for routine assessment has not emerged to date. First signs of change in acute and chronic health status occur in peripheral blood flow. Mission to provide non-invasive products allowing cost-effective & routine assessment of capillary blood flow changes, i.e. microcirculation. Targeting vital care,hemodynamics, wound healing and chronic disease.
Team
-
Dr. Irene JaffeChief Executive Officer -
Ilya SkoletskyChief Technology Officer -
Dr. Daniel WeissChief Medical Officer -
James KleinburdChairman of the Board -
Bruce AndersonSVP and Manager of US Operations
Advisors
-
David Gitlin, Esq., GreenbergTraurig, Philadephia, PALawyerUnconfirmed
David Evans, Cherry Hill, NJAccountantUnconfirmed
Previous Investors
-
Dotan Technologies Ltd.Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.